Introduction
Cervical dystonia is a chronic neurological movement disorder, which is usually known as spasmodic torticollis. This disease is recognised by involuntary muscle contractions in the neck that result in repeated motions and abnormal head positions. It can have a major effect on a person's quality of life because of the pain, discomfort, and social embarrassment that is associated with this disease.
Cervical dystonia's exact cause is still unknown, although data indicate that environmental and genetic factors are responsible for the development of this disease. This illness may be inherited by some people, but in other cases, symptoms may be brought on by some external factors like physical trauma or drug use.
Preventive measures, targeted therapy, and early diagnosis all depend on an understanding of how these genetic factors and environmental factors interact. The present understanding of the genetic and environmental risk factors and their contributions to the development of cervical dystonia is examined in this article.1
Overview of cervical dystonia
The most prevalent kind of focal dystonia is cervical dystonia, which usually appears in adulthood, usually between the ages of 30 and 60. It causes the muscles of the neck to contract continuously, which in turn causes the head and neck to twist, tilt, or jerk periodically.
Classification
Primary (Idiopathic) cervical dystonia
Potential hereditary predisposition is the only reason responsible for this.
Secondary cervical dystonia
Has a known aetiology, such as drug-induced movement problems, stroke, or head trauma.
Epidemiology
About 30 to 50 people out of 100,000 are affected. It is more prevalent in women than in males. It appears gradually, and it can get worse over time if not treated on time.2
Clinical features
Involuntary contraction of neck muscles causes abnormal head positions (e.g., torticollis, laterocollis, retrocollis), neck pain and discomfort, head tremor in some cases. Symptoms often worsen with stress or fatigue and improve with sensory tricks (e.g., lightly touching the face).
Genetic risk factors
Although the inheritance pattern of cervical dystonia can be complicated and unknown, genetic susceptibility plays a key role in its development. Variable penetrance and gene–environment interactions are indicated by the fact that many cases appear sporadic, even though some patients have a documented family history.
Familial occurrence
According to research, 10–25% of cervical dystonia patients have a first-degree relative who also has tremor or dystonia. Because of the limited penetrance and often autosomal dominant inheritance pattern, not all gene carriers have symptoms.
Candidate genes
Although their function in cervical dystonia is still being studied, many genes have been linked to dystonia syndromes:
- TOR1A (DYT1): rarely linked with focal cervical dystonia as it is more strongly associated with generalised dystonia
- THAP1 (DYT6): linked to early-onset dystonia, which may affect the cervical area
- GNAL: mutations are particularly associated with cervical dystonia that develops in adults
- ANO3: linked to cervical dystonia and dystonic tremor3
Genetic susceptibility and modifiers
Many carriers of genes linked to dystonia do not exhibit any symptoms, which can be explained by reduced penetrance. The onset, severity, and development of cervical dystonia may be influenced by modifier genes and epigenetic changes
Limitations in genetic understanding
Despite significant family connections, many cases are still idiopathic. Small sample sizes and demographic heterogeneity are the limitations of current research. To identify more susceptibility loci, larger genome-wide association studies (GWAS) are required.
Environmental risk factors
Environmental factors frequently function as triggers for the development of cervical dystonia, even when genetics offers a foundation for susceptibility. These environmental factors can worsen an underlying condition or cause symptoms to appear in susceptible people.
Trauma and injury
Among the most common causes are neck injuries like whiplash or repeated strain. The fact that symptoms frequently appear weeks or months after trauma suggests a delayed effect.
Infections
Post-infectious dystonia may result from bacterial or viral infections. Mechanisms may involve autoimmune reactions or inflammation that may affect the basal ganglia.
Toxins and drug exposure
Secondary dystonia is closely associated with medications that inhibit dopamine receptors, such as antipsychotics and antiemetics. Although there is still little proof but long-term exposure to environmental pollutants such as heavy metals may also be involved.
Stress and psychological factors
Anxiety and emotional strain can exacerbate the symptoms of dystonia. According to some research, long-term psychological stress could serve as a trigger for the onset of this disease.
Occupational and lifestyle factors
Risk has been linked to repetitive neck motions, poor ergonomics, or prolonged postural strain (e.g., in manufacturing workers, musicians). Fatigue and lack of sleep can also make symptoms worse.4
Interaction between genetic and environmental Factors
The development of cervical dystonia is rarely explained by genetics or environment alone. Rather, a multifactorial approach in which environmental triggers and genetic susceptibility interact with each other is supported by the majority of the data.
Epigenetic mechanisms
Environmental exposures can change how genes are expressed without altering DNA sequences via means of histone modification and DNA methylation. These alterations might be the reason why some gene carriers experience no symptoms at all, while others develop cervical dystonia.
Timing of environmental exposures
The impact of diseases or injuries that happen during specific critical periods (like early adulthood) could be greater. Environmental factors may be more likely to affect younger people with genetic risk.
Gene–environment synergy
For instance, cervical dystonia may only appear in a person with a GNAL mutation following neck trauma. Stress or drug use might be a "second hit" for genetically susceptible people.
Evidence from research
Twin studies suggest that genetics plays a role, but discordance among identical twins highlights environmental influence. Although heredity may be involved, discordance between identical twins emphasises the impact of the environment.
Non-genetic modifiers also play a role, as evidenced by family studies that reveal variation in symptom intensity even among carriers of the same mutation.5
Research and current studies
The fundamental causes of cervical dystonia have been investigated in recent years, with an increasing emphasis on precise genetic markers and understanding the part played by environmental triggers.
Advances in genetic research
Genome-wide association studies (GWAS)
identified several loci that may be related to the susceptibility of cervical dystonia,
highlighting how neural signalling pathways, particularly the cholinergic and dopaminergic systems, are involved.
Next-generation sequencing
Contributed to the identification of ANO3 and GNAL mutations, which are both closely linked to adult-onset cervical dystonia.
Ongoing challenges
There are still many examples that cannot be explained genetically, indicating polygenic or multifactorial inheritance.
Environmental studies
- Trauma research: Although the exact cause is still up for discussion, longitudinal research shows that a significant proportion of patients report neck trauma before cervical dystonia appears
- Drug-induced cases: Studies show a clear correlation between secondary dystonia and long-term dopamine antagonist usage
- Stress and lifestyle factors: Chronic stress and sleep deprivation may worsen symptoms, according to some prospective research, but there is currently little evidence to support this
Neuroimaging and neurophysiology
The theory of network dysfunction is supported by functional MRI and PET investigations, which reveal abnormal connections in basal ganglia–cortical circuits.
Cervical dystonia patients have impaired sensory integration, according to electrophysiological investigations.
Future directions
Data on family cases will be gathered through extensive worldwide genetic registries.
Looking into how the environment and genetic predisposition are mediated by epigenetic modifications is very helpful.
Assessment of environmental exposures
Clinical trials exploring tailored treatments according to environmental and genetic characteristics.
Implications for diagnosis and treatment
Comprehending the environmental and genetic risk factors for cervical dystonia not only clarifies its aetiology but also helps in developing effective diagnostic and therapeutic approaches.
Diagnostic considerations
Family history
To determine genetic susceptibility, clinicians should collect a thorough family history, history of neck injuries, drug usage (particularly dopamine antagonists), infections, or occupational risk factors.
Neuroimaging and Genetic Testing
To rule out secondary reasons, MRI may be utilised. Mutations (e.g., GNAL, ANO3) in suspected familial cases can be confirmed by genetic testing.
Personalised treatment approaches
Botulinum toxin injections
The gold standard for treating symptoms is still botulinum toxin injections, which are customised for each patient's unique muscle involvement.
Medication
Benzodiazepines, muscle relaxants, and anticholinergics may offer further relief.
Deep brain stimulation (DBS)
When treating severe, drug-resistant instances, especially in genetically proven dystonia, deep brain stimulation (DBS) may be an option.
Stress and lifestyle management
Physiotherapy, relaxation methods, and ergonomic changes can all help lessen the intensity of symptoms.
Preventive and early intervention strategies
Those with a familial history or a history of trauma may be identified early so they can get closer monitoring and early treatment. One should stay clear of well-known triggers, such as needless dopamine-blocking drugs. Educating patients about neck care, good posture, and stress management may slow down the development.
Conclusion
A complicated neurological condition, cervical dystonia results from the interaction of environmental factors and genetic predisposition. Environmental factors such as trauma, infections, stress, and drug exposure frequently serve as catalysts for the onset of symptoms, even though certain gene alterations, such as those in GNAL and ANO3, have been associated with higher vulnerability. The significance of gene–environment interactions and potential epigenetic pathways is shown by the variation in presentation, even among genetically related people.
The complex nature of this illness is being increasingly revealed by ongoing research, especially in the fields of neuroimaging and genetics. Knowing these risk factors improves the accuracy of diagnoses and helps guide preventative and individualised treatment plans. Ultimately, enhancing the quality of life for people with cervical dystonia requires an all-encompassing strategy that takes into account both hereditary and acquired factors.
References
- Velickovic M, Benabou R, Brin MF. Cervical dystonia: pathophysiology and treatment options. Drugs [Internet]. 2001 [cited 2025 Jul 30];61(13):1921–43. Available from: http://link.springer.com/10.2165/00003495-200161130-00004
- Defazio G, Jankovic J, Giel JL, Papapetropoulos S. Descriptive epidemiology of cervical dystonia. Tremor and Other Hyperkinetic Movements [Internet]. 2013 Nov 4 [cited 2025 Jul 30];3(0):03. Available from: https://tremorjournal.org/article/10.5334/tohm.170/
- Siokas V, Aloizou AM, Tsouris Z, Michalopoulou A, Mentis AFA, Dardiotis E. Risk factor genes in patients with dystonia: a comprehensive review. Tremor Other Hyperkinet Mov (N Y). 2018;8:559.
- Defazio G, Gigante AF. The environmental epidemiology of primary dystonia. Tremor Other Hyperkinet Mov (N Y) [Internet]. 2013 May 3 [cited 2025 Jul 30];3:tre-03-131-3076-1. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628345/
- Liu C, Scorr L, Kilic-Berkmen G, Cotton A, Factor SA, Freeman A, et al. A metabolomic study of cervical dystonia. Parkinsonism & Related Disorders [Internet]. 2021 Jan [cited 2025 Jul 30];82:98–103. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1353802020308725

